CBIH (Cannabis Bioscience International Holdings) Other Current Payables: $0.85 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cannabis Bioscience International Holdings Other Current Payables?

Cannabis Bioscience International Holdings CBIH +33.33% Other Current Payables is $0.85 Mil as of Feb. 2026. The stock has 4 warning signs investors should review.

Cannabis Bioscience International Holdings's Other Current Payables for the quarter that ended in Feb. 2026 was $0.85 Mil.

Cannabis Bioscience International Holdings's quarterly Other Current Payables increased from Aug. 2025 ($0.72 Mil) to Nov. 2025 ($0.79 Mil) and increased from Nov. 2025 ($0.79 Mil) to Feb. 2026 ($0.85 Mil).

Cannabis Bioscience International Holdings's annual Other Current Payables increased from May. 2023 ($0.11 Mil) to May. 2024 ($0.52 Mil) and increased from May. 2024 ($0.52 Mil) to May. 2025 ($0.62 Mil).

Cannabis Bioscience International Holdings Other Current Payables Related Terms

Cannabis Bioscience International Holdings Other Current Payables Historical Data

* Premium members only.

The historical data trend for Cannabis Bioscience International Holdings's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabis Bioscience International Holdings Other Current Payables Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11 May23 May24 May25
Other Current Payables
Get a 7-Day Free Trial 2.27 3.79 0.11 0.52 0.62

Cannabis Bioscience International Holdings Quarterly Data
Nov10 Feb11 May11 Aug11 Nov11 Feb12 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.62 0.72 0.79 0.85

Cannabis Bioscience International Holdings Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.85 Mil mean?
Cannabis Bioscience International Holdings (CBIH) has a Other Current Payables of $0.85 Mil as of Feb. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Cannabis Bioscience International Holdings and its competitors.
Is Cannabis Bioscience International Holdings' Other Current Payables too high?
Cannabis Bioscience International Holdings' current Other Current Payables is $0.85 Mil.
How does Cannabis Bioscience International Holdings' Other Current Payables compare to SXTC and UPC?
Cannabis Bioscience International Holdings' Other Current Payables of $0.85 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Cannabis Bioscience International Holdings and its competitors. Cannabis Bioscience International Holdings's current Other Current Payables is $0.85 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Bioscience International Holdings stock overvalued right now?
Cannabis Bioscience International Holdings (CBIH) has a current Other Current Payables of $0.85 Mil. The current Other Current Payables is $0.85 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Cannabis Bioscience International Holdings (CBIH), the current Other Current Payables is $0.85 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabis Bioscience International Holdings Business Description

Address 6201 Bonhomme Road, Suite 435N, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc operates in three main areas. Firstly, the company engages in cannabis-related research and education under the trade name Pharmacology University. Secondly, it serves as both a Sponsor and a Contract Research Organization (CRO) in clinical trials, some of which involve cannabis and CBD products, under the trade name Alpha Research Institute. Lastly, the company plans to manufacture, market, and sell CBD products branded as "VitaCookies." The majority of the company's revenue comes from clinical trial contracts, while a smaller portion is generated from cannabis-related educational classes and seminars.